News

The Greater Bay Area International Clinical Trial Institute (GBAICTI) held our inaugural Hong Kong CRO Partners Connect this week, bringing together 10 leading CROs to exchange views on strengthening Hong Kong’s clinical trial ecosystem.

The discussion went beyond trial activation to the broader clinical trial journey – from feasibility and site selection to timelines and coordination. Valuable insights were shared on improving efficiency, enhancing predictability, and fostering greater consistency across processes.

There was also strong emphasis on highlighting Hong Kong’s unique strengths to global sponsors, while continuing to expand research capacity and broaden investigator participation.

As a connector across stakeholders, GBAICTI will continue to facilitate these important conversations and help bring industry perspectives forward.

Thank you to all our CRO partners for your openness and valuable contributions. This is just the beginning of ongoing collaboration to advance clinical research in Hong Kong.